Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 生物資源暨農學院
  3. 食品科技研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26945
標題: 利用蛹蟲草發酵黃耆來開發抗腫瘤活性製品
Developing anti-tumor activity products from culturing Cordyceps militaris in Radix astragali
作者: Yu-Wei Lin
林育蔚
指導教授: 蔣丙煌(Been-Huang Chiang)
關鍵字: 黃耆,蛹蟲草,發酵,腫瘤,BALB/c小鼠,
Radix astragalus,Cordyceps militaris,Fermentation,Tumor,BALB/c mice,
出版年 : 2008
學位: 博士
摘要: 黃耆是常見的中藥,具有促進淋巴細胞增生、免疫調節、抗癌活性和抗肝損傷等功能。本研究即利用黃耆當作培養基以蛹蟲草當作菌種進行發酵,期望得到具有抗癌活性之發酵產品。結果顯示相較於化學合成培養基,以黃耆當作培養基之發酵濾液擁有較高之抗癌活性,其抑制癌細胞生長能力(IC50)對人類胃癌細胞AGS、人類乳癌細胞MCF-7、人類肝癌細胞Hep G2和老鼠大腸癌細胞CT26分別為465、37、25 和20 μg/mL。進一步以CT26接種於BALB/c小鼠之動物模式來評估抗癌活性,實驗結果指出相較於控制組,當每天以管餵方式餵食100 mg/kg BW/day和200 mg/kg BW/day劑量時,可以有效抑制腫瘤的體積達43.81 %和48.89 %,而腫瘤重量的抑制率方面分別為31.21 %和39.48 %,皆能有效的抑制腫瘤生成。此外,發酵濾液在動物實驗過程中並無發現對於小鼠臟器有任何明顯的副作用。在成分分析方面,結果顯示,黃耆皂苷、黃耆異黃酮皆非主要抗癌活性來源,接著以HPLC進行分離純化後,發現波鋒2與蟲草素組合時具有最好的抗癌活性表現。
Radix astragalus is widely used in China. Radix astragalus was demonstrated to have various bioactivities such as lymphocyte proliferation, immune-regulation, anti-tumor activity, and anti-liver injury. This study used Radix astragali (RA) as the medium for culturing Cordyceps militaris to investigate the anti-tumor activity of the fermentation broth. It was found that the product from culturing C. militaris in RA medium had a better anti-tumor activity than that culturing in synthetic medium. The fermentation broth inhibited the growth of four tumor cells including human gastric cancer AGS cells, human breast cancer MCF-7 cells, human hepatocellular carcinoma Hep G2 cells and murine colorectal adenocarcinoma CT26 cells with IC50 465μg/mL, 37μg/mL, 25μg/mL, and 20μg/mL, respectively. To validate the anti-tumor activity, the BALC/c mice were implanted with CT26 cells and then fed with various dosages of the fermentation product. It was found that 20 mg/kg body weight (BW)/day group had no significant anti-tumor activity as compared to the control group. The dosage of 100 mg/kg BW/day and 200 mg/kg BW/day group inhibited the tumor volume by 43.81% and 48.89%. Tumor weight was also reduced by 31.21% and 39.48% compared to the control group. Besides, the fermentation broth didn’t impose serious side effect on the vital organs of the mice as compared to the chemotherapeutic drug 5-FU. After constituent analyses, the results showed that saponins and isoflavonoids of Astragalus were not the major anti-tumor components. Through HPLC isolation, when cordycepin combined with peak 2 had the strongest anti-tumor activity.
URI: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/26945
全文授權: 未授權
顯示於系所單位:食品科技研究所

文件中的檔案:
檔案 大小格式 
ntu-97-1.pdf
  目前未授權公開取用
910.57 kBAdobe PDF
顯示文件完整紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved